Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)

Min Wang; Christopher C. Ebmeier; John R. Olin; Robert J. Anderson

doi:10.1016/j.steroids.2005.11.003

Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)

Min Wang, Christopher C. Ebmeier, John R. Olin, Robert J. Anderson

Department of Medicine

Research output: Contribution to journal › Article

14 Scopus citations

Abstract

Sulfation is a major pathway in humans for the biotransformation of steroid hormones and structurally related therapeutic agents. Tibolone is a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis. Sulfation inactivates the hydroxylated metabolites, 3α-hydroxytibolone (3α-OH-tibolone) and 3β-hydroxytibolone (3β-OH-tibolone), and contributes to the regulation of tissue responses to tibolone. We detected SULT1A1, SULT1A3, SULT1E1 and SULT2A1 mRNA expression by RT-PCR in postmenopausal liver and small intestine. Liver pool (n = 5) SULT activities measured with tibolone substrates reflected COS-1 expressed SULT2A1 and SULT1E1 activities. Liver SULT2A1 activity (1.8 ± 0.3 units/mg protein, n = 8, mean ± SEM), and activities with 3α-OH-tibolone (0.6 ± 0.1, n = 8) and 3β-OH-tibolone (0.9 ± 0.2, n = 8) were higher than SULT1E1 activities (

Original language	English (US)
Pages (from-to)	343-351
Number of pages	9
Journal	Steroids
Volume	71
Issue number	5
DOIs	https://doi.org/10.1016/j.steroids.2005.11.003
State	Published - May 1 2006

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Biology
Endocrinology
Pharmacology
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.steroids.2005.11.003

Fingerprint Dive into the research topics of 'Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)'. Together they form a unique fingerprint.

Cite this

Wang, M., Ebmeier, C. C., Olin, J. R., & Anderson, R. J. (2006). Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs). Steroids, 71(5), 343-351. https://doi.org/10.1016/j.steroids.2005.11.003

@article{a87a3a9085eb4782abca0387ad3e5f70,

title = "Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)",

abstract = "Sulfation is a major pathway in humans for the biotransformation of steroid hormones and structurally related therapeutic agents. Tibolone is a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis. Sulfation inactivates the hydroxylated metabolites, 3α-hydroxytibolone (3α-OH-tibolone) and 3β-hydroxytibolone (3β-OH-tibolone), and contributes to the regulation of tissue responses to tibolone. We detected SULT1A1, SULT1A3, SULT1E1 and SULT2A1 mRNA expression by RT-PCR in postmenopausal liver and small intestine. Liver pool (n = 5) SULT activities measured with tibolone substrates reflected COS-1 expressed SULT2A1 and SULT1E1 activities. Liver SULT2A1 activity (1.8 ± 0.3 units/mg protein, n = 8, mean ± SEM), and activities with 3α-OH-tibolone (0.6 ± 0.1, n = 8) and 3β-OH-tibolone (0.9 ± 0.2, n = 8) were higher than SULT1E1 activities (",

author = "Min Wang and Ebmeier, {Christopher C.} and Olin, {John R.} and Anderson, {Robert J.}",

year = "2006",

month = may,

day = "1",

doi = "10.1016/j.steroids.2005.11.003",

language = "English (US)",

volume = "71",

pages = "343--351",

journal = "Steroids",

issn = "0039-128X",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)

AU - Wang, Min

AU - Ebmeier, Christopher C.

AU - Olin, John R.

AU - Anderson, Robert J.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Sulfation is a major pathway in humans for the biotransformation of steroid hormones and structurally related therapeutic agents. Tibolone is a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis. Sulfation inactivates the hydroxylated metabolites, 3α-hydroxytibolone (3α-OH-tibolone) and 3β-hydroxytibolone (3β-OH-tibolone), and contributes to the regulation of tissue responses to tibolone. We detected SULT1A1, SULT1A3, SULT1E1 and SULT2A1 mRNA expression by RT-PCR in postmenopausal liver and small intestine. Liver pool (n = 5) SULT activities measured with tibolone substrates reflected COS-1 expressed SULT2A1 and SULT1E1 activities. Liver SULT2A1 activity (1.8 ± 0.3 units/mg protein, n = 8, mean ± SEM), and activities with 3α-OH-tibolone (0.6 ± 0.1, n = 8) and 3β-OH-tibolone (0.9 ± 0.2, n = 8) were higher than SULT1E1 activities (

AB - Sulfation is a major pathway in humans for the biotransformation of steroid hormones and structurally related therapeutic agents. Tibolone is a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis. Sulfation inactivates the hydroxylated metabolites, 3α-hydroxytibolone (3α-OH-tibolone) and 3β-hydroxytibolone (3β-OH-tibolone), and contributes to the regulation of tissue responses to tibolone. We detected SULT1A1, SULT1A3, SULT1E1 and SULT2A1 mRNA expression by RT-PCR in postmenopausal liver and small intestine. Liver pool (n = 5) SULT activities measured with tibolone substrates reflected COS-1 expressed SULT2A1 and SULT1E1 activities. Liver SULT2A1 activity (1.8 ± 0.3 units/mg protein, n = 8, mean ± SEM), and activities with 3α-OH-tibolone (0.6 ± 0.1, n = 8) and 3β-OH-tibolone (0.9 ± 0.2, n = 8) were higher than SULT1E1 activities (

UR - http://www.scopus.com/inward/record.url?scp=33646074319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646074319&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2005.11.003

DO - 10.1016/j.steroids.2005.11.003

M3 - Article

C2 - 16360722

AN - SCOPUS:33646074319

VL - 71

SP - 343

EP - 351

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 5

ER -